BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4744591)

  • 1. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formal discussion of F. Teillet et al's paper, "a reappraisal of clinical and biological signs in staging of Hodgkin's disease.
    Kaplan HS
    Cancer Res; 1971 Nov; 31(11):1730. PubMed ID: 5121675
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
    Wolf PL; Ray G; Kaplan H
    Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulocyte alkaline phosphatase activity in Hodgkin's disease.
    Bobory J
    Acta Med Acad Sci Hung; 1971; 28(1):1-5. PubMed ID: 5133497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of determination of ceruloplasmin activity and haptoglobin level in patients with lymphogranulomatosis].
    Vasygova NF; Lorie IuI
    Vestn Akad Med Nauk SSSR; 1974; (12):20-4. PubMed ID: 4446705
    [No Abstract]   [Full Text] [Related]  

  • 12. The serum iron level, hematocrit, sedimentation rate, and leukocyte alkaline phosphatase level in pediatric patients with Hodgkin's disease.
    Jaffe N; Bishop JM
    Cancer; 1970 Aug; 26(2):332-7. PubMed ID: 5456754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of leukocyte alkaline phosphatase in Hodgkin's disease.
    Bennett JM; Nathanson L; Rutenburg AM
    Arch Intern Med; 1968 Apr; 121(4):338-41. PubMed ID: 5645706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum complement level in Hodgkin's disease].
    Hamladji RM; Belhani M; Irunberry J; Benabadji M; Colonna P
    Nouv Rev Fr Hematol; 1972; 12(5):673-81. PubMed ID: 4120941
    [No Abstract]   [Full Text] [Related]  

  • 17. Haematological and clinical parameters in assessing activity in Hodgkin's disease and other malignant lymphomas.
    Simmons AV; Spiers AS; Fayers PM
    Q J Med; 1973 Jan; 42(165):111-24. PubMed ID: 4569732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some laboratory indicators of lymphogranulomatosis].
    Vasygova NF
    Sov Med; 1973 Aug; 36(8):57-62. PubMed ID: 4130223
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hodgkin's disease. Lymphoadenography, cupremia and sideremia].
    Weissleder H; Marongiu F
    Prensa Med Argent; 1966 May; 53(18):1001-7. PubMed ID: 5916206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.